Status:
NOT_YET_RECRUITING
Early Life Exposures Among Children With Sickle Cell Disease
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Sickle Cell Disease
Adverse Childhood Experiences
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
This study is being conducted to determine the relationship between early childhood exposures, such as Adverse Childhood Experiences, Social Determinants of Health and nutrition/breastfeeding, among c...
Detailed Description
During year 3 of the award period, 20 mother-infant dyads will be randomly assigned to either a community-based breastfeeding support group or observation. Acceptability to enrollment, intervention ad...
Eligibility Criteria
Inclusion
- mother of infant with sickle cell disease
- resides within the city of Birmingham, Alabama or in close proximity
Exclusion
- prescribed teratogenic medications
- no/limited internet access
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05377372
Start Date
September 1 2025
End Date
December 31 2027
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233